Skip to content

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02411461
Enrollment
39
Registered
2015-04-08
Start date
2014-12-01
Completion date
2017-01-31
Last updated
2019-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism

Keywords

Pediatric obesity, pseudohypoparathyroidism, Albright Hereditary Osteodystrophy

Brief summary

Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.

Detailed description

Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder that causes early-onset, syndromic obesity and cognitive impairment. This study aims to evaluate eating behaviors, cognition and executive function in children with PHP1a, compared with healthy siblings and matched obese controls.

Interventions

None listed

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of PHP1a, sibling of a patient with PHP1a or matched obese control

Exclusion criteria

(PHP1a): * Treatment with appetite-altering drug or initiation of a new weight loss program in the past 3 months * Type 2 diabetes

Design outcomes

Primary

MeasureTime frameDescription
Intelligence Quotientone dayIntelligence quotient as measured by Kaufman Brief Intelligence Test, 2nd Edition. This scale yields standard scores where the mean is 100 and one standard deviation is 15. Higher scores indicate better function.

Countries

United States

Participant flow

Participants by arm

ArmCount
Pseudohypoparathyroidism Type 1a
Study group
16
Healthy Siblings
Control group
8
Obese Patients
Control group
15
Total39

Baseline characteristics

CharacteristicPseudohypoparathyroidism Type 1aHealthy SiblingsObese PatientsTotal
Age, Categorical
<=18 years
16 Participants8 Participants15 Participants39 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
16 Participants8 Participants15 Participants39 Participants
Sex: Female, Male
Female
10 Participants5 Participants11 Participants26 Participants
Sex: Female, Male
Male
6 Participants3 Participants4 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 80 / 15
other
Total, other adverse events
0 / 160 / 80 / 15
serious
Total, serious adverse events
0 / 160 / 80 / 15

Outcome results

Primary

Intelligence Quotient

Intelligence quotient as measured by Kaufman Brief Intelligence Test, 2nd Edition. This scale yields standard scores where the mean is 100 and one standard deviation is 15. Higher scores indicate better function.

Time frame: one day

ArmMeasureValue (MEAN)Dispersion
Pseudohypoparathyroidism Type 1aIntelligence Quotient85.9 units on a scaleStandard Deviation 17.2
Healthy SiblingsIntelligence Quotient104.3 units on a scaleStandard Deviation 8.9
Obese PatientsIntelligence Quotient103.2 units on a scaleStandard Deviation 11.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026